BOLD
Boundless Bio·NASDAQ
--
--(--)
--
--(--)
BOLD fundamentals
Boundless Bio (BOLD) released its earnings on Aug 5, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.7 (YoY +9.09%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.7
+9.09%
Report date
Aug 5, 2025
Earnings Call
7:00 AM on Aug 5, 2025
Meeting link.EPS
Actual | -0.77 | -0.71 | -0.7 |
Forecast | -0.8 | -0.735 | -0.65 |
Surprise | +3.75% | +3.40% | -7.69% |
Revenue
Actual | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Boundless Bio's revenue and profit?What were the key takeaways from Boundless Bio’s earnings call?What is Boundless Bio's latest dividend and current dividend yield?What is the market's earnings forecast for Boundless Bio next quarter?What does Boundless Bio do and what are its main business segments?Did Boundless Bio beat or miss consensus estimates last quarter?What were the key takeaways from Boundless Bio's earnings call?What guidance did Boundless Bio's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
